Therapy-related acute myelogenous leukemia and myelodysplastic syndrome
- PMID: 17706165
- DOI: 10.1007/s11912-007-0050-z
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome
Abstract
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/MDS) are increasing in prevalence with aging of the population and improved survival of patients treated with chemotherapy or radiotherapy for other malignancies. Research focused on the pathogenesis of t-AML/MDS will provide insight into the pathogenesis of de novo AML/MDS. Participation in clinical trials should be encouraged for this patient population because results with available treatment options are clearly suboptimal.
Similar articles
-
Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity.PLoS One. 2016 Jul 18;11(7):e0159189. doi: 10.1371/journal.pone.0159189. eCollection 2016. PLoS One. 2016. PMID: 27428079 Free PMC article.
-
Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.Blood. 2002 Feb 1;99(3):822-4. doi: 10.1182/blood.v99.3.822. Blood. 2002. PMID: 11806982
-
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.Leukemia. 2010 Dec;24(12):2056-62. doi: 10.1038/leu.2010.218. Epub 2010 Oct 21. Leukemia. 2010. PMID: 20962860
-
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.J Cancer Res Clin Oncol. 1998;124(3-4):207-14. doi: 10.1007/s004320050156. J Cancer Res Clin Oncol. 1998. PMID: 9619748 Review.
-
Therapy-related myeloid neoplasms.Am J Clin Pathol. 2009 Sep;132(3):410-25. doi: 10.1309/AJCPD85MCOHHCOMQ. Am J Clin Pathol. 2009. PMID: 19687318 Review.
Cited by
-
Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome - a retrospective analysis of the Polish Adult Leukemia Group.Contemp Oncol (Pozn). 2024;28(2):149-157. doi: 10.5114/wo.2024.141727. Epub 2024 Jul 24. Contemp Oncol (Pozn). 2024. PMID: 39421707 Free PMC article.
-
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome.Clin Exp Med. 2024 Feb 8;24(1):33. doi: 10.1007/s10238-023-01287-8. Clin Exp Med. 2024. PMID: 38329593 Free PMC article.
-
Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement.Cell. 2023 Oct 12;186(21):4528-4545.e18. doi: 10.1016/j.cell.2023.09.009. Epub 2023 Oct 2. Cell. 2023. PMID: 37788669 Free PMC article.
-
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.Bone Marrow Transplant. 2023 Dec;58(12):1331-1338. doi: 10.1038/s41409-023-02082-5. Epub 2023 Aug 31. Bone Marrow Transplant. 2023. PMID: 37653054
-
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.Blood Adv. 2022 Feb 22;6(4):1278-1295. doi: 10.1182/bloodadvances.2021005335. Blood Adv. 2022. PMID: 34794172 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous